Based on genetically modified mouse models, such as LPL−/−, GPIHBP1−/−, and ApoC3 transgenic mice, triglycerides were demonstrated to promote atherosclerosis (5, 32–34). The gene discussed is GPIHBP1; the disease is atherosclerosis.